Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models-Reference-Cited by-同舟云学术

Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models

Published:2024-01-11 Issue:1 Volume:25 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Kaistha Brajesh P.¹,Kar Gozde¹,Dannhorn Andreas²,Watkins Amanda¹,Opoku-Ansah Grace¹,Ilieva Kristina¹³,Mullins Stefanie¹⁴,Anderton Judith¹,Galvani Elena¹,Garcon Fabien¹,Lapointe Jean-Martin⁵,Brown Lee²,Hair James¹,Slidel Tim¹,Luheshi Nadia¹,Ryan Kelli¹,Hardaker Elizabeth¹,Dovedi Simon¹,Kumar Rakesh⁶,Wilkinson Robert W.¹,Hammond Scott A.⁶,Eyles Jim¹^ORCID

Affiliation:

1. Oncology R & D, AstraZeneca, Cambridge, UK

2. Imaging Sciences, AstraZeneca, Cambridge, UK

3. Immunooncology, MorphoSys AG, Planegg, Germany

4. Translational Science, F-Star, Cambridge, UK

5. Oncology Safety Pathology, AstraZeneca, Cambridge, UK

6. Oncology R & D, AstraZeneca, Gaithersburg, MD, USA

Funder

no funding associated with the work

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2023.2296048

Reference50 articles.

1. Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response

2. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine;Blay J;Cancer Res,1997

3. Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy

4. CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection

5. Barriers to Radiation-Induced In Situ Tumor Vaccination